Follow
Estefania Moreno
Title
Cited by
Cited by
Year
Cannabinoid receptors CB1 and CB2 form functional heteromers in brain
L Callén, E Moreno, P Barroso-Chinea, D Moreno-Delgado, A Cortés, ...
Journal of Biological Chemistry 287 (25), 20851-20865, 2012
2902012
Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors
MR Pazos, N Mohammed, H Lafuente, M Santos, E Martínez-Pinilla, ...
Neuropharmacology 71, 282-291, 2013
2352013
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
X Viñals, E Moreno, L Lanfumey, A Cordomí, A Pastor, R de La Torre, ...
PLoS biology 13 (7), e1002194, 2015
2062015
Circadian-Related Heteromerization of Adrenergic and Dopamine D4 Receptors Modulates Melatonin Synthesis and Release in the Pineal Gland
S González, D Moreno-Delgado, E Moreno, K Pérez-Capote, R Franco, ...
PLoS biology 10 (6), e1001347, 2012
1852012
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine
G Navarro, E Moreno, M Aymerich, D Marcellino, PJ McCormick, J Mallol, ...
Proceedings of the National Academy of Sciences 107 (43), 18676-18681, 2010
1842010
Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors
C Ferrada, E Moreno, V Casadó, G Bongers, A Cortés, J Mallol, EI Canela, ...
British journal of pharmacology 157 (1), 64-75, 2009
1782009
Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer
J Bonaventura, G Navarro, V Casadó-Anguera, K Azdad, W Rea, ...
Proceedings of the National Academy of Sciences 112 (27), E3609-E3618, 2015
1622015
Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers
G Navarro, E Moreno, J Bonaventura, M Brugarolas, D Farre, D Aguinaga, ...
PloS one 8 (4), e61245, 2013
1422013
Functional selectivity of allosteric interactions within G protein–coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer
X Guitart, G Navarro, E Moreno, H Yano, NS Cai, M Sánchez-Soto, ...
Molecular pharmacology 86 (4), 417-429, 2014
1372014
Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway
E Moreno, H Hoffmann, M Gonzalez-Sepulveda, G Navarro, V Casado, ...
Journal of biological chemistry 286 (7), 5846-5854, 2011
1352011
Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling
E Moreno, C Andradas, M Medrano, MM Caffarel, E Pérez-Gómez, ...
Journal of Biological Chemistry 289 (32), 21960-21972, 2014
1322014
Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers
G Navarro, S Ferré, A Cordomi, E Moreno, J Mallol, V Casadó, A Cortés, ...
Journal of Biological Chemistry 285 (35), 27346-27359, 2010
1312010
Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs
G Navarro, A Cordomí, M Zelman-Femiak, M Brugarolas, E Moreno, ...
BMC biology 14, 1-12, 2016
1252016
Dopamine D4 receptor, but not the ADHD-associated D4. 7 variant, forms functional heteromers with the dopamine D2S receptor in the brain
S González, C Rangel-Barajas, M Peper, R Lorenzo, E Moreno, F Ciruela, ...
Molecular psychiatry 17 (6), 650-662, 2012
1252012
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
E Pérez-Gómez, C Andradas, S Blasco-Benito, MM Caffarel, ...
Journal of the National Cancer Institute 107 (6), djv077, 2015
1182015
Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase
G Navarro, A Cordomí, V Casadó-Anguera, E Moreno, NS Cai, A Cortés, ...
Nature communications 9 (1), 1242, 2018
1162018
The endocannabinoid system as a target in cancer diseases: are we there yet?
E Moreno, M Cavic, A Krivokuca, V Casadó, E Canela
Frontiers in pharmacology 10, 445673, 2019
1122019
Allosteric mechanisms within the adenosine A2A–dopamine D2 receptor heterotetramer
S Ferré, J Bonaventura, D Tomasi, G Navarro, E Moreno, A Cortés, ...
Neuropharmacology 104, 154-160, 2016
1062016
l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus
J Bonaventura, AJ Rico, E Moreno, S Sierra, M Sánchez, N Luquin, ...
Neuropharmacology 79, 90-100, 2014
1002014
Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain
G Navarro, A Cordomí, M Brugarolas, E Moreno, D Aguinaga, ...
Bmc Biology 16, 1-15, 2018
882018
The system can't perform the operation now. Try again later.
Articles 1–20